英特集团(000411) - 2017 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period reached CNY 4,746,342,292.85, a year-on-year increase of 7.26%[8] - Net profit attributable to shareholders decreased by 6.52% to CNY 18,194,679.02 compared to the same period last year[8] - The weighted average return on net assets decreased by 0.45% to 2.25% for the reporting period[8] Assets and Liabilities - Total assets increased by 28.31% to CNY 8,965,376,732.72 compared to the end of the previous year[8] - Accounts receivable increased by 41.03% compared to the end of the previous year, attributed to revenue growth and extended payment terms[15] - Prepayments increased by 138.22% due to higher advance payments for medical equipment and pharmaceuticals[15] - Intangible assets grew by 32.82% due to the acquisition of land use rights by a subsidiary[15] - Goodwill increased by 180.32% as a result of goodwill arising from business combinations under common control[15] - Short-term borrowings increased by 229.05% compared to the end of the previous year, mainly due to the optimization of the financing structure, business expansion, and increased working capital from the "three flows integration" strategy[16] - Accounts payable grew by 33.35% compared to the end of the previous year, primarily due to increased pharmaceutical procurement payments and mergers with enterprises not under common control[16] - Total current liabilities and total liabilities increased by 33.99% and 34.43% respectively compared to the end of the previous year, mainly due to increases in short-term borrowings and accounts payable[16] - Long-term borrowings increased by 172.50% compared to the end of the previous year, attributed to borrowings obtained by the subsidiary Jinhua Yingtai Medical Logistics Co., Ltd.[16] Cash Flow - The company's cash flow from operating activities showed a net outflow of CNY 1,212,091,890.81 for the year-to-date[8] - Operating cash flow net amount decreased by 310.40 million yuan year-on-year, primarily due to increased net outflow from procurement payments and sales receipts[18] - Cash and cash equivalents increased by 91.01 million yuan year-on-year, mainly due to an increase in net cash flow from financing activities[20] - The balance of cash and cash equivalents at the end of the period increased by 41.96% year-on-year, attributed to the increase in net cash[21] - Investment activity cash outflows increased by 35.78% year-on-year, mainly due to increased cash payments for investments and cash payments for acquiring subsidiaries[20] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 8,860[11] Taxation - Tax and additional charges increased by 45.28% year-on-year, mainly due to the implementation of the "Value-Added Tax Accounting Treatment Regulations" affecting property tax and stamp duty reporting[17] Other Payables - Other payables increased by 84.86% compared to the end of the previous year, mainly due to increased deposits and inter-company transactions, as well as mergers with enterprises not under common control[16]